HuGE Literature Finder
Records
1
-
3
Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. Leukemia research 2019 Apr 81 75-81. Spunarova Michaela, Tom Nikola, Pavlova Sarka, Mraz Marek, Brychtova Yvona, Doubek Michael, Panovska Anna, Skuhrova Francova Hana, Brzobohata Anna, Pospisilova Sarka, Mayer Jiri, Trbusek Mart |
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015 Feb 29 (2): 329-36. Baliakas P, Hadzidimitriou A, Sutton L-A, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli M J J, Smedby K E, Juliusson G, Anagnostopoulos A, Makris A M, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford J C, Stamatopoulos K, Rosenquist R, |
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. Leukemia & lymphoma 2014 Dec 55 (12): 2785-92. Chiaretti Sabina, Marinelli Marilisa, Del Giudice Ilaria, Bonina Silvia, Piciocchi Alfonso, Messina Monica, Vignetti Marco, Rossi Davide, Di Maio Valeria, Mauro Francesca Romana, Guarini Anna, Gaidano Gianluca, Foà Rob |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: